Safety, Tolerability and Pharmacokinetics Study in Patients with Pulmonary Arterial Hypertension (PAH) Temporarily Switching from Oral to IV Selexipag

被引：3

作者：

Klose, H. ^{[1
]}

Chin, K. ^{[2
]}

Ewert, R. ^{[3
]}

Gall, H. ^{[4
]}

Parambil, J. ^{[5
]}

Poch, D. ^{[6
]}

Seyfarth, H. ^{[7
]}

Axelsen, L. ^{[8
]}

Schmitz, S. Hsu ^{[9
]}

Stein, C. ^{[10
]}

Preston, I. ^{[11
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Dept Resp Med, Ctr Oncol, Hamburg, Germany

[2] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[3] Ernst Moritz Arndt Univ Greifswald, Dept Resp Med, Clin Internal Med, Greifswald, Germany

[4] UGMLC, Internal Med, Giessen, Germany

[5] Cleveland Clin, Dept Pulm Allergy & Crit Care Med, Resp Inst, Cleveland, OH 44106 USA

[6] Univ Calif San Diego, Dept Pulm Crit Care, San Diego, CA 92103 USA

[7] Univ Leipzig, Dept Resp Med, Leipzig, Germany

[8] Actel Pharmaceut Ltd, Clin Pharmacol, Allschwil, Switzerland

[9] Actel Pharmaceut Ltd, Biostat, Allschwil, Switzerland

[10] Actel Pharmaceut Ltd, Clin Sci, Allschwil, Switzerland

[11] Tufts Univ, Sch Med, Tufts Med Ctr, Pulm Crit Care & Sleep Div, Boston, MA 02111 USA

来源：

关键词：

D O I：

10.1016/j.healun.2019.01.1247

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1237

引用

页码：S490 / S490

页数：1